Tolerability and Safety and Health Outcomes in Relapsing Multiple Sclerosis (MS) Patients

NCT01127750 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
2417
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis